Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
Setting Sights on Ocular Disorders
New Therapeutic Options Are in Development for Age-Related Macular Degeneration
- Age-related macular degeneration (AMD) is one of the leading causes of blindness. There are two forms of AMD—wet and dry. Currently, the majority of therapeutics being developed are for wet AMD ( Figure ). The standard therapy for wet AMD is anti-VEGF injections. The benefit of these injections ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.